Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 9Head & Neck 6Dermatologic 6CNS 3Myeloid 2Lymphoid 2Breast 2Other hematologic neoplasm 1Genitourinary 1Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 881Precursor Cell Lymphoblastic Leukemia-Lymphoma 509Hematologic Neoplasms 464Leukemia, Lymphocytic, Chronic, B-Cell 392Leukemia 335Myelodysplastic Syndromes 329Lymphoma 207Lymphoma, Non-Hodgkin 191Multiple Myeloma 146Leukemia, Myelogenous, Chronic, BCR-ABL Positive 142Recurrence 138Neoplasms 134Leukemia, Myelomonocytic, Chronic 111Lymphoma, Mantle-Cell 92Lymphoma, Follicular 92Burkitt Lymphoma 92Lymphoma, Large B-Cell, Diffuse 91Myeloproliferative Disorders 84Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 83Leukemia, Biphenotypic, Acute 81Lymphoma, B-Cell, Marginal Zone 75Hodgkin Disease 72Lymphoma, B-Cell 64Waldenstrom Macroglobulinemia 54Primary Myelofibrosis 53Leukemia, B-Cell 52Anemia, Refractory, with Excess of Blasts 46Leukemia, Myeloid, Chronic-Phase 41Hematologic Diseases 37Lymphoma, T-Cell 33

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Soft Tissue Neoplasms × Other hematologic neoplasm × 1 year × Clear all
NCT04996875 2026-05-05

APEX

Cogent Biosciences, Inc.

Phase 2 Recruiting
140 enrolled
LymphoidMyeloidOther hematologic neoplasm

Hematologic Diseases, Hypersensitivity, Immune Complex Diseases, Immune System Diseases, Leukemia, Leukemia, Mast-Cell, Leukemia, Myeloid, Mastocytosis, Myeloproliferative Disorders, Neoplasms, Neoplasms by Site, Neoplasms, Connective Tissue, Skin Diseases, Soft Tissue Neoplasms, Urticaria Pigmentosa, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡